Letter
Administering multiple cumulative allergen challenges: An alternative nasal allergen challenge protocol for the Allergic Rhinitis–Clinical Investigator Collaborative

https://doi.org/10.1016/j.anai.2016.06.025Get rights and content

First page preview

First page preview
Click to open first page preview

References (10)

There are more references available in the full text version of this article.

Cited by (0)

Disclosures: In the past 12 months, Dr Ellis has participated in advisory boards for Circassia Ltd, GSK, Merck, and Novartis; she has been a speaker for Novartis, Merck, Pfizer, Takeda, and AstraZeneca; and her institution received research grants from GSK, Circassia Ltd, SunPharma, Merck, Pfizer, and Novartis. Dr Ellis is also a consultant to Ora Inc and ALK-Abello, Canada. Dr Neighbour has received support from GSK and Adiga Lifesciences and has served on the speaker's bureau and received honoraria from Merck, Astra-Zeneca, GSK, and Novartis. No other disclosures were reported.

Funding Sources: This study was supported by the AllerGen Network Centre of Excellence, Project #12CIC-AR, and the William M. Spear Endowment Fund/Start Memorial Fund.

View full text